Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 200 | 3 | ONCOLOGY//PACLITAXEL//THYMIDYLATE SYNTHASE | 52806 |
| 978 | 2 | 5 FLUOROURACIL//DIHYDROPYRIMIDINE DEHYDROGENASE//THYMIDINE PHOSPHORYLASE | 10904 |
| 11703 | 1 | URIDINE PHOSPHORYLASE//5 PHENYLTHIOACYCLOURIDINE//URIDINE | 988 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | URIDINE PHOSPHORYLASE | authKW | 646856 | 4% | 52% | 39 |
| 2 | 5 PHENYLTHIOACYCLOURIDINE | authKW | 191388 | 1% | 100% | 6 |
| 3 | URIDINE | authKW | 133723 | 4% | 12% | 36 |
| 4 | 5 PHENYLSELENENYLACYCLOURIDINE | authKW | 95694 | 0% | 100% | 3 |
| 5 | URIDINE PHOSPHORYLASE INHIBITOR | authKW | 95694 | 0% | 100% | 3 |
| 6 | 5 FLUOROURIDINE DERIVATIVE | authKW | 63796 | 0% | 100% | 2 |
| 7 | ATCASE INHIBITORS | authKW | 63796 | 0% | 100% | 2 |
| 8 | TRIACETYLURIDINE | authKW | 63796 | 0% | 100% | 2 |
| 9 | PALA | authKW | 63784 | 1% | 25% | 8 |
| 10 | CANCER TREATMENT REPORTS | journal | 43753 | 6% | 3% | 55 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 5234 | 38% | 0% | 379 |
| 2 | Pharmacology & Pharmacy | 1603 | 25% | 0% | 247 |
| 3 | Biochemistry & Molecular Biology | 468 | 22% | 0% | 213 |
| 4 | Biophysics | 184 | 6% | 0% | 59 |
| 5 | Chemistry, Medicinal | 114 | 4% | 0% | 39 |
| 6 | Crystallography | 48 | 3% | 0% | 25 |
| 7 | Biochemical Research Methods | 34 | 3% | 0% | 29 |
| 8 | Physiology | 8 | 2% | 0% | 20 |
| 9 | Chemistry, Multidisciplinary | 6 | 5% | 0% | 50 |
| 10 | Chemistry, Organic | 5 | 3% | 0% | 28 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | BIOCHEM SIMMONS COMPREHENS CANC | 31898 | 0% | 100% | 1 |
| 2 | BIOL BIOCIENCIAS RIO CLARO | 31898 | 0% | 100% | 1 |
| 3 | BIOMERIEUX SA PATHOPHYSIOL INJURY INDUCED IMMUNOS | 31898 | 0% | 100% | 1 |
| 4 | BRAIN KOREA CHUNGBUK BIOMED SCI 21 | 31898 | 0% | 100% | 1 |
| 5 | CHEM S HIROMACHI 1258 SHINAGAWA KU | 31898 | 0% | 100% | 1 |
| 6 | CHIM BIO ORGAN | 31898 | 0% | 100% | 1 |
| 7 | CLIN CANC NURSING SERV | 31898 | 0% | 100% | 1 |
| 8 | CLIN PHARMACOL BRANCH CANC TREATMENT | 31898 | 0% | 100% | 1 |
| 9 | CNRS ERA 195 | 31898 | 0% | 100% | 1 |
| 10 | CNRS UMR 7631 | 31898 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANCER TREATMENT REPORTS | 43753 | 6% | 3% | 55 |
| 2 | CANCER RESEARCH | 6793 | 9% | 0% | 92 |
| 3 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 6763 | 4% | 1% | 40 |
| 4 | BIOCHEMICAL PHARMACOLOGY | 6734 | 6% | 0% | 63 |
| 5 | ADVANCES IN ENZYME REGULATION | 6454 | 1% | 2% | 11 |
| 6 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 2419 | 1% | 1% | 12 |
| 7 | JOURNAL OF PHARMACOBIO-DYNAMICS | 1941 | 1% | 1% | 10 |
| 8 | ADVANCES IN PHARMACOLOGY AND CHEMOTHERAPY | 1770 | 0% | 6% | 1 |
| 9 | MOLECULAR PHARMACOLOGY | 1682 | 2% | 0% | 23 |
| 10 | INVESTIGATIONAL NEW DRUGS | 1469 | 1% | 0% | 11 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |